The new AXBarrier-on-Chip System includes breakthrough 3D stretch features to easily mimic any organ barrier of your choice.
Bern, Switzerland – March 16, 2023
AlveoliX announced the launch of its latest product, the AXBarrier-on-Chip System. The new system will be unveiled at the upcoming SOT & ToxExpo in Nashville from March 19 - 23.
The AXBarrier-on-Chip System is a cutting-edge platform that enables the study of biological barriers such as the lung or gut barrier and many others. The system is designed to replicate the complex micro-environment of organ barriers taking into account the mechanical forces. It allows researchers now to model any organ and customize the applied forces, ranging from physiological to pathophysiological.
The AXBarrier-on-Chip System will be available immediately following its launch at the SOT conference. Interested parties are encouraged to visit the AlveoliX booth (#1406) for a demonstration of the system's capabilities.
"We are thrilled to introduce our AXBarrier-on-Chip System to the scientific community at the SOT conference," said Dr. Janick Stucki, CEO of AlveoliX. "Our team has worked tirelessly to develop a platform that meets the needs of researchers around the world. We believe that the AXBarrier-on-Chip System represents a significant step forward in the field of in vitro studies for modelling the microenvironment including the mechanical forces of different organs."
To celebrate the launch of the AXBarrier-on-Chip System, AlveoliX will be hosting a contest at its booth (#1406) during the SOT conference. The winner will receive a free one-year research plan using our new system. The contest will be open to academic researchers attending SOT conference and ToxExpo. For more information on this, follow our LinkedIn page: https://www.linkedin.com/company/alveolix/
AlveoliX’s mission is to make organs-on-chips the new standard for preclinical decision-making and the leading alternative to animal experiments. For more information, visit www.alveolix.com or contact us at email@example.com.